Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy

DOI Web Site Web Site 被引用文献9件

書誌事項

公開日
2003-08-29
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1002/cncr.11660
公開者
Wiley

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:sec><jats:title>BACKGROUND</jats:title><jats:p>Neoadjuvant chemotherapy has shown some success in the treatment of gastric carcinoma, but objective parameters for measuring its effects are lacking. The authors performed the current study to determine which histomorphologic features are correlated with patient prognosis after chemotherapy.</jats:p></jats:sec><jats:sec><jats:title>METHODS</jats:title><jats:p>Thirty‐six patients with gastric carcinoma were treated with a combination of etoposide, doxorubicin, and cisplatin. The entire tumor beds of the specimens were evaluated histologically and compared with specimens treated with surgery alone. Thirty‐four patients were available for survival analysis (follow‐up period, 60–130 months).</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>None of the 36 patients had complete tumor regression, 4 patients had marked regression (less than 10% viable tumor), 9 patients had regression to 10–50% remaining viable tumor, and 23 patients had more than 50% viable tumor remaining. Currently, 9 patients are still alive (5‐year survival rate, 27%). Tumor regression was found to be correlated significantly with survival (<jats:italic>P</jats:italic> = 0.01), but tumor size (<jats:italic>P</jats:italic> = 0.002) and lymphatic vessel invasion (<jats:italic>P</jats:italic> = 0.003) were better predictors of prognosis.</jats:p></jats:sec><jats:sec><jats:title>CONCLUSIONS</jats:title><jats:p>Histologic tumor regression grade is an objective measure of the effects of neoadjuvant chemotherapy in patients with gastric carcinoma, but its accuracy may be improved by adding additional staging variables such as tumor size and lymphatic vessel involvement. Cancer 2003;98:1521–30. © 2003 American Cancer Society.</jats:p><jats:p>DOI 10.1002/cncr.11660</jats:p></jats:sec>

収録刊行物

  • Cancer

    Cancer 98 (7), 1521-1530, 2003-08-29

    Wiley

被引用文献 (9)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ